Literature DB >> 10544967

Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.

S Shetty1, S Idell.   

Abstract

The urokinase-type plasminogen activator (uPA) interacts with its receptor (uPAR) to promote proteolysis as well as cell proliferation and migration. These functions contribute to the pathogenesis of neoplastic growth and invasiveness. Expression of uPAR in tumor extracts also inversely correlates with prognosis in many forms of cancer. In this study, we sought to determine if differences in uPAR expression were distinguishable between cultured human lung carcinoma and malignant mesothelioma subtypes. We also sought to determine if, as in malignant mesothelioma cells, uPAR expression is regulated at the posttranscriptional level in cultured malignant lung carcinoma cells. Using 125I-uPA binding and ligand blotting techniques, uPAR was expressed by phenotypically diverse lung carcinoma cell lines, including the H460, H157 and H1395 non-small cell lines and the H146 small cell lung carcinoma line. Increased uPAR expression was also detected in spindle-shaped (M33K) and epithelioid (M9K and MS-1) malignant mesothelioma cells. Selected mediators, including TGF-beta, TNF-alpha, LPS and PMA, uniformly enhanced uPAR expression in each of the tumor cell lines. Steady state uPAR mRNA expression was determined by RNase protection assay and correlated directly with the changes in cell surface uPAR expression. By gel mobility shift and UV-cross linking assays, a uPAR mRNA binding protein (uPAR mRNABp) implicated in the posttranscriptional control of message stability, was identified in each of the cell lines. Expression of uPAR and its message in cultured lung carcinoma and malignant mesothelioma cells is similarly influenced by effectors present in the tumor microenvironment. Regulation of the uPAR message occurs at the posttranscriptional level in cultured small and non-small cell lung carcinoma cells as well as spindle-shaped and fibrous malignant mesothelioma cell lines. Posttranscriptional regulation of uPAR in all these cells involves the interaction of the uPAR mRNABp with uPAR mRNA, which promotes uPAR mRNA destabilization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544967     DOI: 10.1023/a:1006914800447

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.

Authors:  F Jänicke; M Schmitt; H Graeff
Journal:  Semin Thromb Hemost       Date:  1991-07       Impact factor: 4.180

3.  Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.

Authors:  S Shetty; A Kumar; S Idell
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  Cell-associated plasminogen activation: regulation and physiological functions.

Authors:  O Saksela; D B Rifkin
Journal:  Annu Rev Cell Biol       Date:  1988

5.  Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.

Authors:  D Boyd; G Florent; P Kim; M Brattain
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

6.  Plasminogen activator in bladder tumors.

Authors:  S Mitsubayashi; T Akiyama; T Kurita; K Okada; H Bando; T Sakai; O Matsuo
Journal:  Urol Res       Date:  1987

7.  Urokinase receptor and colorectal cancer survival.

Authors:  S Ganesh; C F Sier; M M Heerding; G Griffioen; C B Lamers; H W Verspaget
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

8.  Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.

Authors:  M Yebra; G C Parry; S Strömblad; N Mackman; S Rosenberg; B M Mueller; D A Cheresh
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

9.  The urokinase receptor is required for human monocyte chemotaxis in vitro.

Authors:  M R Gyetko; R F Todd; C C Wilkinson; R G Sitrin
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Prevention of metastasis by inhibition of the urokinase receptor.

Authors:  C W Crowley; R L Cohen; B K Lucas; G Liu; M A Shuman; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  10 in total

1.  Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.

Authors:  Sreerama Shetty; Thirunavukkarasu Velusamy; Steven Idell; Praveenkumar Shetty; Andrew P Mazar; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

2.  Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.

Authors:  Torry A Tucker; LaTerrica Williams; Kathleen Koenig; Hema Kothari; Andrey A Komissarov; Galina Florova; Andrew P Mazar; Timothy C Allen; Khalil Bdeir; L Vijaya Mohan Rao; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

4.  Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity.

Authors:  J J Provost; D Rastedt; J Canine; T Ngyuen; A Haak; C Kutz; N Berthelsen; A Slusser; K Anderson; G Dorsam; M A Wallert
Journal:  Cell Oncol (Dordr)       Date:  2012-01-31       Impact factor: 6.730

5.  The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.

Authors:  Torry A Tucker; Candice Dean; Andrey A Komissarov; Kathy Koenig; Andrew P Mazar; Usha Pendurthi; Timothy Allen; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-27       Impact factor: 6.914

6.  Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.

Authors:  Sreerama Shetty; Praveenkumar Shetty; Steven Idell; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  J Biol Chem       Date:  2008-05-09       Impact factor: 5.157

7.  The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.

Authors:  Romaine I Fernando; Mary Litzinger; Paola Trono; Duane H Hamilton; Jeffrey Schlom; Claudia Palena
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

8.  Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Hong-Long Ji; Pierre F Neuenschwander; Vijay Boggaram; Gilbert F Morris; Jian Fu; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2013-05-08       Impact factor: 4.307

9.  Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.

Authors:  Praveenkumar Shetty; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty; Ming-Cheh Liu; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-03       Impact factor: 6.914

10.  A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.

Authors:  Hiroshi Kobayashi; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.